CLIN.L - Clinigen Group Plc

LSE - LSE Delayed Price. Currency in GBp

Clinigen Group Plc

Pitcairn House
Crown Square Centrum 100
Burton-on-Trent DE14 2WW
United Kingdom
44 1283 495 010

IndustryMedical Distribution
Full Time Employees849

Key Executives

NameTitlePayExercisedYear Born
Mr. Shaun Edward ChiltonCEO & Exec. Director893kN/A1968
Mr. Nicholas KeherCFO & DirectorN/AN/AN/A
Ms. Debra AingeChief Operating OfficerN/AN/AN/A
Matt ParrishHead of Investor RelationsN/AN/AN/A
Mr. David BryantDirector of Corp. Devel.N/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.


Clinigen Group plc operates as a specialty pharmaceutical and services company. The company operates through three segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires and licenses commercial medicines and then revitalises them, as well as provides access to licensed and branded generic medicines in the Africa and Asia Pacific region. The Unlicensed Medicines segment is involved in sourcing and supplying unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Segment supplies and manages comparator medicines and services to clinical trials and investigator initiated trials. It offers Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Foscavir, an anti-virals which work by stopping viruses from multiplying in number; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company has a strategic alliance with Cumberland Pharmaceuticals Inc. Clinigen Group plc was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.

Corporate Governance

Clinigen Group Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.